At a glance
- Originator Fisons
- Class Amines; Anti-inflammatories; Benzyl compounds; Pyrazoles; Skin disorder therapies; Small molecules
- Mechanism of Action 5-lipoxygenase inhibitors; Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Crohn's disease; Inflammatory bowel diseases; Psoriasis; Rheumatic disorders; Ulcerative colitis
Most Recent Events
- 18 Jun 1998 Discontinued-II for Crohn's disease in United Kingdom (Unknown route)
- 18 Jun 1998 Discontinued-II for Inflammatory bowel disease in United Kingdom (Unknown route)
- 26 Sep 1997 Discontinued-II for Psoriasis in United Kingdom (Topical)